Literature DB >> 2203304

Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.

G R Aronoff1, R A Brier, R S Sloan, M E Brier.   

Abstract

We studied the in vivo interaction of ceftazidime and tobramycin in normal volunteers and anuric patients given each drug separately or both drugs in combination. Kinetic analysis of plasma concentration data showed minor changes in the disposition of these agents when they were given concurrently. However, the resulting clearance of both tobramycin and ceftazidime was unchanged when these drugs were given concurrently. The volume of distribution of tobramycin at steady state was increased by 20% in normal volunteers when given with ceftazidime. The increase in distribution was accompanied by a slight decrease in ceftazidime elimination rate. No additional alteration in dosing over those necessary to adjust for a decrease in renal function is necessary when giving this combination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203304      PMCID: PMC171772          DOI: 10.1128/AAC.34.6.1139

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Interactions of carbenicillin and ticarcillin with gentamicin.

Authors:  M Davies; J R Morgan; C Anand
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

4.  Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

Authors:  J Klastersky; A Henri; L Vandenborre
Journal:  Am J Med Sci       Date:  1973-07       Impact factor: 2.378

5.  Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin.

Authors:  V T Andriole
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

6.  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.

Authors:  L J Riff; G G Jackson
Journal:  Arch Intern Med       Date:  1972-12

7.  Combined use of gentamicin and carbenicillin.

Authors:  R E Winters; A W Chow; R H Hecht; W L Hewitt
Journal:  Ann Intern Med       Date:  1971-12       Impact factor: 25.391

8.  Biological aspects of the interaction between gentamicin and carbenicillin.

Authors:  J A Waitz; C G Drube; E L Moss; E M Oden; J V Bailey
Journal:  J Antibiot (Tokyo)       Date:  1972-04       Impact factor: 2.649

9.  In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.

Authors:  C B Smith; J N Wilfert; P E Dans; T A Kurrus; M Finland
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

10.  Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.

Authors:  G R Aronoff; M E Brier; D M Nierste; R S Sloan
Journal:  J Infect Dis       Date:  1984-01       Impact factor: 5.226

View more
  1 in total

1.  Lack of pharmacokinetic interaction between cefepime and amikacin in humans.

Authors:  R H Barbhaiya; C A Knupp; M Pfeffer; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.